About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • Released: July 18, 2005
    According to Food and Drug Administration (FDA), some 80,000 medical devices are marketed in the United States, ranging from those as simple as plastic tubing and baby bottle nipples to others as complex as pacemakers or cerebrospinal fluid shunts. Although low-risk devices like plastic tubing need not be evaluated by FDA before going to market, between 55 percent and 60 percent of all devices are considered to be higher risk and require agency review before they can enter the market. In this IOM study, sponsored by the FDA, the committee was charged with evaluating FDA's postmarket surveillance of medical devices used with children specifically.
  • Released: June 03, 2005
    This report reviews the unique circumstances of soldiers deployed in short-term, high intensity missions; by considering health concerns, food intake, energy expenditure, physical exercise and food technology issues, the report gives recommendations on the nutritional composition of daily rations for assault missions.
  • Released: June 01, 2005
    The Institute of Medicine of the AffiliateMarketIngtools held a workshop, December 13-14, 2004, to estimate the contributions of lifestyle-related factors to preventable death.
  • Released: May 23, 2005
    This study, titled Improving Breast Imaging Quality Standards, examines the current practice of mammography and breast cancer detection, with a focus on the FDA's Mammography Quality Standards Act (MQSA) oversight, and identifies areas in need of improvement.
  • Released: May 13, 2005
    In Integrating Employee Health: A Model Program for NASA the committee found that NASA has a history of being forward-looking in designing programs aimed at improving the health and wellness of its employees.
  • Released: May 01, 2005
    As part of its study, the committee held a workshop at the Instituto Nacional de Salud Publica (National Institute of Public Health) in Cuernavaca, Mexico, in September 2004. The purpose of the workshop was to sample global perspectives on the current advancing technology landscape.
  • Released: April 27, 2005
    This report provides guidelines for the conduct of hES cell research to address both ethical and scientific concerns. The guidelines are intended to enhance the integrity of privately funded hES cell research by encouraging responsible practices in the conduct of that research.
  • Released: April 27, 2005
    The committee concluded that it was time for a change in the WIC food packages and the report provides details on the proposed new food packages, summarizes how the proposed packages differ from current packages, and discusses the rationale for the proposed packages.
  • Released: April 19, 2005
    Healers Abroad: Americans Responding to the Human Resource Crisis in HIV/AIDS, recommends that the federal government create and fund an umbrella organization called the United States Global Health Service (GHS) to mobilize the nation's best health care professionals and other experts to help combat HIV/AIDS in hard-hit African, Caribbean, and Southeast Asian countries.
  • Released: April 18, 2005
    Continued improvements in survival of childhood and adolescent cancer and less toxic outcomes will be achieved only with new chemical and biological agents. Despite a wealth of tantalizing leads from basic science, there is a near-complete void in commercial R&D for pediatric cancer. There is another way to harness the disparate activities already in existence to discover and develop new drugs for pediatric cancers. Making Better Drugs for Children with Cancer describes a practical approach to joining the capabilities of the National Institutes of Health, academic laboratories, and the pharmaceutical industry in a virtual R&D network.
HGH Frag 176-191

Buy Masteron online